Boston Scientific Corp BSX on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery ...
Boston Scientific has issued an FDA warning letter recommending removal of 1,660 lots of AXIOS Stent and Electrocautery Enhanced Delivery Systems due to increased reports of stent deployment and ...
Add Yahoo as a preferred source to see more of our stories on Google. Boston Scientific's headquarters is in Marlborough, Massachusetts. (Courtesy of Boston Scientific) This story was originally ...
The FDA sent an early safety alert warning clinicians of deployment failures with certain Boston Scientific AXIOS Stent and Electrocautery Enhanced Delivery Systems that have been linked to three ...
The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE: BSX) has alerted customers to remove certain AXIOS stents and electrocautery-enhanced delivery ...
The RAINBOW study, officially titled “French Prospective Study on Biliary Tract Drainage Guided by Endoscopic Ultrasound in Patients With Malignant Biliary Stenosis (RAINBOW),” evaluates Boston ...